Adalimumab Proves Effective For Children With Juvenile Rheumatoid Arthritis
Mon, 13 Nov 2006 08:00 AM EST
... Adalimumab, an injectable anti-TNF therapy that has FDA approval for treating rheumatoid arthritis in adults, has proven effective in children with juvenile rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC. [click link for full article] ...
Related Topics
- Rheumatoid Arthritis
- Juvenile Rheumatoid Arthritis
- Arthritis
- Adalimumab
- Rheumatoid Factor
- Rituximab
- Arthritis, Rheumatoid
- Septic Arthritis
- Reactive Arthritis
- Infliximab
- Juvenile Diabetes
- Etanercept
- Juvenile primary lateral sclerosis
- Osteoarthritis
- Autoimmune Diseases
- Amyotrophic lateral sclerosis, type 2
- Incarceration
- Rheumatoid spondylitis
- Disease-modifying anti-rheumatoid drugs
- Acetaminophen Oral Suspension or Syrup

Not Signed In -


